ScoreWhy is Orchid Pharma Ltd ?
1
Weak Long Term Fundamental Strength with an average Return on Equity (ROE) of 5.10%
- Poor long term growth as Net Sales has grown by an annual rate of 12.51% and Operating profit at 15.95% over the last 5 years
2
Flat results in Mar 26
- PAT(Latest six months) At Rs 17.74 cr has Grown at -58.81%
- ROCE(HY) Lowest at 2.48%
- DEBT-EQUITY RATIO(HY) Highest at 0.28 times
3
With ROCE of 0.4, it has a Very Expensive valuation with a 3.3 Enterprise value to Capital Employed
- The stock is trading at a premium compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of 34.35%, its profits have fallen by -73%
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Orchid Pharma for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Orchid Pharma
34.35%
0.88
38.82%
Sensex
-5.98%
-0.45
13.24%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
12.51%
EBIT Growth (5y)
15.95%
EBIT to Interest (avg)
2.10
Debt to EBITDA (avg)
4.96
Net Debt to Equity (avg)
0.22
Sales to Capital Employed (avg)
0.57
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
21.12%
ROCE (avg)
1.65%
ROE (avg)
5.10%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
181
Industry P/E
34
Price to Book Value
3.78
EV to EBIT
906.95
EV to EBITDA
125.25
EV to Capital Employed
3.29
EV to Sales
6.35
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
0.36%
ROE (Latest)
2.09%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
Bearish
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Bullish
Bearish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
No Trend
Mildly Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend13What is working for the Company
PBT LESS OI(Q)
At Rs 14.91 cr has Grown at 917.0% (vs previous 4Q average
OPERATING PROFIT TO INTEREST(Q)
Highest at 8.70 times
NET SALES(Q)
Highest at Rs 237.61 cr
PAT(Q)
Highest at Rs 23.24 cr.
EPS(Q)
Highest at Rs 4.69
-14What is not working for the Company
PAT(Latest six months)
At Rs 17.74 cr has Grown at -58.81%
ROCE(HY)
Lowest at 2.48%
DEBT-EQUITY RATIO(HY)
Highest at 0.28 times
DEBTORS TURNOVER RATIO(HY)
Lowest at 3.07 times
Loading Valuation Snapshot...
Here's what is working for Orchid Pharma
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 14.91 cr has Grown at 917.0% (vs previous 4Q average)
over average PBT of the previous four quarters of Rs -1.83 CrMOJO Watch
Near term PBT trend is very positive
PBT less Other Income (Rs Cr)
Profit After Tax (PAT) - Quarterly
At Rs 23.24 cr has Grown at 257.8% (vs previous 4Q average)
over average PAT of the previous four quarters of Rs 6.50 CrMOJO Watch
Near term PAT trend is very positive
PAT (Rs Cr)
Operating Profit to Interest - Quarterly
Highest at 8.70 times
in the last five quartersMOJO Watch
The company's ability to manage interest payments is improving
Operating Profit to Interest
Net Sales - Quarterly
Highest at Rs 237.61 cr
in the last five quartersMOJO Watch
Near term sales trend is positive
Net Sales (Rs Cr)
Profit After Tax (PAT) - Quarterly
Highest at Rs 23.24 cr.
in the last five quartersMOJO Watch
Near term PAT trend is positive
PAT (Rs Cr)
Earnings per Share (EPS) - Quarterly
Highest at Rs 4.69
in the last five quartersMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (Rs)
Here's what is not working for Orchid Pharma
Debt-Equity Ratio - Half Yearly
Highest at 0.28 times and Grown
each half year in the last five half yearly periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio
Debtors Turnover Ratio- Half Yearly
Lowest at 3.07 times
in the last five half yearly periodsMOJO Watch
Company's pace of settling its Debtors has slowed
Debtors Turnover Ratio
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
